IFNA1 and interstitial lung disease: Patients with de novo or inherited c.842G>A p.(Arg281Gln) heterozygosity present with IFN activation and typical SAVI features such as ILD, failure to thrive, cough, dyspnea, and cutaneous necrotizing vasculitis (34–37).